Siemens Healthineers AG SEMHF · Stock Open Siemens Healthineers AG in new tab
Siemens Healthineers AG Analysis (SEMHF)
Is Siemens Healthineers AG a good investment? Siemens Healthineers AG (SEMHF) is currently trading at 47.17 USD.
In terms of valuation, the stock trades at a P/E ratio of 20.69. This valuation is generally in line with the broader market.
Earnings Schedule: Siemens Healthineers AG is expected to release its next earnings report on Nov. 5, 2026.
For income investors, Siemens Healthineers AG pays a dividend yield of 2.51%. With a payout ratio of 51%, the dividend appears sustainable.
Investor FAQ
Does Siemens Healthineers AG pay a dividend?
Yes, it pays an annual dividend of 1.19 USD (2.51% yield).
What asset class is Siemens Healthineers AG?
Siemens Healthineers AG is classified as a Stock. You can compare it against 5 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be Nov. 5, 2026. The company currently has a trailing EPS of 2.28.
Company Profile
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers magnetic resonance imaging, computed tomography, X-ray, molecular imaging, and ultrasound systems; and software solutions to support the reading and structured reporting of diagnostic images from different modalities. Its Diagnostics segment provides in-vitro diagnostic products and services to healthcare providers in the fields of general and specialty laboratory, and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment offers microwave, cryoablation, and embolization technologies, as well as clinical professional services for cancer care that support oncology departments in hospitals and clinics; and customized support for cancer care operations. Its Advanced Therapies segment provides products that are designed to support image-guided minimally invasive clinical procedures in various areas, such as cardiology, neurology, and oncology; angiography systems and mobile C-arms; and AI-powered clinical applications. It also offers essential technical customer service, such as maintenance and repair; spare parts; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as healthcare consulting, products, and services. It has strategic partnership with IFS to increase product lifecycle with industrial AI. The company was founded in 1896 and is headquartered in Forchheim, Germany. Siemens Healthineers AG is a subsidiary of Siemens Aktiengesellschaft.
| Year | Total Dividends |
|---|---|
| ▸2027 |
1.26 USD
|
| Feb. 17, 2027 (estimated) | 1.2622 |
| ▸2026 |
1.19 USD
|
| Feb. 10, 2026 | 1.1912 |
| ▸2025 |
1.00 USD
|
| Feb. 21, 2025 | 0.9950 |
| ▸2024 |
1.01 USD
|
| April 23, 2024 | 1.0122 |
| ▸2023 |
1.01 USD
|
| Feb. 20, 2023 | 1.0139 |
| ▸2022 |
0.97 USD
|
| Feb. 18, 2022 | 0.9661 |
| ▸2021 |
0.80 USD
|
| Feb. 17, 2021 | 0.8000 |
| ▸2020 |
0.87 USD
|
| Feb. 17, 2020 | 0.8679 |
| ▸2019 |
0.80 USD
|
| Feb. 8, 2019 | 0.7964 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Siemens Healthineers AG | Feb 10, 2026 | Paid | 1.1912 USD |
Community Discussion